slide1 n.
Skip this Video
Loading SlideShow in 5 Seconds..
Focus on Clinical Research PowerPoint Presentation
Download Presentation
Focus on Clinical Research

Loading in 2 Seconds...

play fullscreen
1 / 25

Focus on Clinical Research - PowerPoint PPT Presentation

  • Uploaded on

Focus on Clinical Research. Entities With Limited Resources. RESPONSIBILITIES 1) Ensure the research responds to the health needs and priorities of the target community 2) Ensure any product or benefit developed will be made available to the community.

I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
Download Presentation

PowerPoint Slideshow about 'Focus on Clinical Research' - chauncey

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.

- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript

Entities With Limited Resources

  • 1) Ensure the research responds to the health needs and priorities of the target community
  • 2) Ensure any product or benefit developed will be made available to the community
responsiveness to community health needs
Responsiveness to Community Health Needs

Successful interventions that result from the research must be made available to the community.

If this is not done, the research is exploitative.

prior agreement
Prior Agreement
  • Before the research begins, offer a plan to make available the product to the host nation when the study is done.
  • In planning investigators should include representatives of the government, local authorities, community members, and NGO groups.
  • The agreement should include decisions about payments, royalties, distribution costs, subsidies, technology, and intellectual property.
  • In some cases, international organizations, public and private, may also be included in the discussions.
need community approval
Need Community Approval
  • Community must have legitimate, empowered spokesperson(s)
  • Community must have a common health-related culture
  • A communication network for the community must be in place
ethical issues
Ethical Issues

Should investigators ever use the standards of care/ethics of a developing countries vs. developed countries in comparisons?

Are investigators responsible for the health of their participants?

Can participants in developing countries understand informed consent (e.g., is there an expectancy of benefit or treatment even if not stated in the informed consent)?

Is it ethical to do research in developing countries on issues relevant to developed countries but not relevant to developing countries?

us irb requirements
US IRB Requirements
  • A. Investigator’s knowledge of the community
  • B. Literacy level and language of population
  • C. Status of women: 1. Ensure volunteer participation. 2. ? Supplemental male permission. 3. Potential benefit to women. 4. Procedures respecting women’s autonomy to consent. 5. Written assurance that in no case will a competent adult woman be enrolled in research solely on permission of another person.
D. Status of children
  • E. How research aqddresses important question related to host community/country
  • F. How to avoid therapeutic misconception
  • G. How at least some of the national population will get beneficial health care
  • Informed consent does not relate to what investigators think they need to disclose. but rather what the participant needs to know!
ensuring protections for research participants
Ensuring Protections for Research Participants
  • Avoiding the “therapeutic misconception.”
    • Helping the patient is not the reason for the research.
  • Critical importance of
  • Participants trust you more than a confusing piece of paper. Be worthy of their trust.
  • Participate in the consenting process and make sure they understand.
human subjects consent form
1. Purpose of the study

2. Procedures

3. Potential risks and discomforts

4. Anticipated benefits to subjects

5. Anticipated benefits to society

6. Alternatives to participation

7. Payment for participation

8. Possible commercial products

9. Sample remaining at the end of the study

10 Financial obligation

11. Emergency care and compensation for injury

12. Privacy and confidentiality

13. Participation and withdrawal

14. Consequences of withdrawal

15. Withdrawal of participation by the investigator

16. New findings

17. Identification of investigators

18. Rights of research subjects

19. Adherence to HIPAA

Human Subjects Consent Form
therapeutic misconception
Therapeutic Misconception
  • Participants often enter clinical trials because they think they will benefit from the treatment.
  • Sometimes the investigator is a little misleading to encourage them to enter, but often, they refuse to hear anything but the possibility of treatment.
influences on voluntary informed consent
Influences on Voluntary Informed Consent
  • Is it voluntary? Is it informed?
  • Vulnerability to incentives
  • Impact of community pressure coercion
  • Intimidating power of investigators
  • Ability of participants to understand procedures, goals, benefits and risks
additional risks of participation
Additional Risks of Participation
  • Stigmatization,
  • Privacy,
  • Confidentiality
Stigmatization = characterizing or branding (a persons) as disgraceful or ignominious
  • (American Heritage Dictionary, 7th Edition, 1992)
  • Privacy = freedom from unsanctioned intrusion
  • (American Heritage Dictionary, 7th edition, 1992)
  • Stolen From Detels

Marginalized groups

  • The poor Ethnic minorities
  • Sex workers Drug users
  • The uneducated (illiterate)
  • Men/women who have sex with persons of the same gender
  • HIV- infected persons
  • Persons infected with sexually transmitted organisms
  • Sexually promiscuous persons
  • Respect for persons guarantees the participants RIGHT to privacy
  • Lack of privacy also reduces willingness to participate.
  • Assertion that privacy is guaranteed is insufficient
  • Participant must perceive that privacy is guaranteed.
  • Investigators must deliver on their promise.
confidentiality vs anonymity
Confidentiality vs Anonymity
  • Name and identifying information are recorded
  • Guarantee that identifying information will not be shared with unauthorized persons
  • That is only as good as the integrity and care of the investigator and staff
  • With anonymity, name and identifying information are not recorded
  • Impossible to trace back results to informant
hipaa and the common rule
HIPAA and The Common Rule
  • HIPAA uses the same definition of research as the federal Common Rule (45 CFR 46), which is “a systematic investigation designed to contribute to generalizeable knowledge.”
  • Research that creates, uses, or discloses personally identifiable information in the course of providing health care services is protected health information (PHI) under the HIPAA Privacy Rule.
  • Research that records personally identifiable health information to characterize and better understand disease processes without associated clinical intervention, is covered by the common rule but is not protected health information under HIPAA.
research that is covered by hipaa
Research That Is Covered By HIPAA
  • Studies that involve review of the medical record (PHI).
  • Studies in which a health care service is being performed such as testing a new way of diagnosing a condition or a new drug or device for treating a health condition, i.e., creating new medical records.
  • In general, if any part of the research is recorded in a medical record
was this an ethical study
Was this an ethical study?
  • Was a placebo control justified
    • If the subjects were children?
    • If the subjects were adults?
  • Seven ethical requirements for clinical research as delineated by Emanuel et al are:
    • scientific value
    • scientific validity
    • fair subject selection
    • favorable risk/benefit ratio
    • independent review
    • informed consent
    • respect for enrolled subjects
ongoing controversies
Ongoing Controversies
  • Placebo groups
  • International or local standards of care
  • Should participants be assured care beyond the trials – if so, for how long?
  • Should care be provided to the trial community?
  • Should trials be evaluated for scale-up feasibility before implementation?